Zoetis Total products and services — Revenue decreased by 5.0% to $2.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.2%, from $2.19B to $2.24B. Over 4 years (FY 2021 to FY 2025), Total products and services — Revenue shows an upward trend with a 5.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong market demand, successful product launches, or expanded market share, while a decrease may signal competitive pressure, loss of patent exclusivity, or cyclical downturns in animal health spending.
This metric represents the aggregate gross revenue generated from the sale of all animal health products, including phar...
Comparable to total net sales reported by other global animal health or pharmaceutical companies, though specific product mix between companion and production animals varies by peer.
zts_segment_total_products_and_services_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.93B | $1.97B | $1.94B | $1.97B | $2.03B | $1.98B | $2.01B | $1.98B | $2.16B | $2.13B | $2.19B | $2.17B | $2.34B | $2.37B | $2.30B | $2.19B | $2.43B | $2.38B | $2.36B | $2.24B |
| QoQ Change | — | +2.1% | -1.4% | +1.3% | +3.4% | -2.7% | +1.7% | -1.5% | +8.9% | -1.4% | +3.0% | -1.0% | +8.0% | +1.0% | -3.0% | -4.6% | +10.7% | -2.0% | -0.8% | -5.0% |
| YoY Change | — | — | — | — | +5.5% | +0.5% | +3.7% | +0.8% | +6.2% | +7.6% | +8.9% | +9.4% | +8.5% | +11.1% | +4.7% | +1.0% | +3.5% | +0.4% | +2.7% | +2.2% |